Adherence in children with growth hormone deficiency treated with r-hGH and the easypod™ device

[1]  G. Johannsson,et al.  Reviewing the safety of GH replacement therapy in adults. , 2015, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[2]  D. Gašperíková,et al.  Improved adipose tissue metabolism after 5-year growth hormone replacement therapy in growth hormone deficient adults: The role of zinc-α2-glycoprotein , 2015, Adipocyte.

[3]  F. Baş,et al.  Adherence to growth hormone therapy: results of a multicenter study. , 2014, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[4]  C. Acerini,et al.  Understanding the Growth Hormone Therapy Adherence Paradigm: A Systematic Review , 2013, Hormone Research in Paediatrics.

[5]  V. Ayyar.  History of growth hormone therapy , 2011, Indian journal of endocrinology and metabolism.

[6]  A. Gunn,et al.  Non-Compliance with Growth Hormone Treatment in Children Is Common and Impairs Linear Growth , 2011, PloS one.

[7]  A. Rogol,et al.  Current indications for growth hormone therapy for children and adolescents. , 2010, Endocrine development.

[8]  M. Tauber,et al.  User trial of Easypod, an electronic autoinjector for growth hormone. , 2008, Annales d'endocrinologie.

[9]  J. Dahlgren.  Easypod™ a new electronic injection device for growth hormone , 2008, Expert review of medical devices.

[10]  M. Tauber,et al.  Observations of nonadherence to recombinant human growth hormone therapy in clinical practice. , 2008, Clinical therapeutics.

[11]  B. Mendonca,et al.  [Growth hormone (GH) deficiency treatment in children: comparison between uses of pen versus bottles/syringes on GH administration]. , 2007, Arquivos brasileiros de endocrinologia e metabologia.

[12]  J. Dahlgren,et al.  Patient acceptance of a novel electronic auto-injector device to administer recombinant human growth hormone: results from an open-label, user survey of everyday use , 2007, Current medical research and opinion.

[13]  J. Kerrigan,et al.  The multiple indications for growth hormone treatment of pediatric patients. , 2006, Pediatric annals.

[14]  M. Elmlinger,et al.  Reference ranges for two automated chemiluminescent assays for serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP-3) , 2004, Clinical chemistry and laboratory medicine.

[15]  P. Hindmarsh,et al.  Compliance with Growth Hormone Treatment – Is It a Problem? , 1999, Hormone Research in Paediatrics.

[16]  M. Fekkes,et al.  Psychological responses to the needle‐free Medi‐Jector® or the multidose Disetronic® injection pen in human growth hormone therapy , 1998, Acta paediatrica.

[17]  M. Thorén,et al.  Patient evaluation of a new injection pen for growth hormone treatment in children and adults , 1995, Acta paediatrica (Oslo, Norway : 1992). Supplement.

[18]  J. T. Jørgensen.  Improvement of patient convenience in treatment with growth hormone. , 1994, The Journal of pediatric endocrinology.

[19]  A. Juul,et al.  Growth Hormone (GH)-Deficiency in Adults: Clinical Features and Effects of GH Substitution , 1994, The Journal of pediatric endocrinology.

[20]  R. Stanhope,et al.  Patient knowledge and compliance with growth hormone treatment. , 1993, Archives of disease in childhood.